FindTrial
Sign In

Effects of ipratropium bromide on the occurrence of postoperative respiratory complications in craniectomy patients with COPD: a nationwide multicenter retrospective study

Effects of ipratropium bromide on the occurrence of postoperative respiratory complications in craniectomy patients with COPD: a nationwide multicenter retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022552
Enrollment
Unknown
Registered
2019-04-16
Start date
2019-05-01
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory complications in craniectomy patients with COPD

Interventions

1:using ipratropium bromide
2:not using using ipratropium bromide

Sponsors

Fudan University Huashan Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 40 and 80 years; 2. Patients received craniectomy; 3. Combined with FEV1/FVC<70% or diagnosed as pulmonary emphysema or history of COPD, chronic bronchitis.

Exclusion criteria

Exclusion criteria: 1. History of pulmonary operations; 2. History of using ipratropium bromide; 3. History of lung cancer; 4. History of pulmonary infection.

Design outcomes

Secondary

MeasureTime frame
incidence of respiratory complications;length of stay;death rate;—

Primary

MeasureTime frame
incidence of pneumonia;—

Countries

China

Contacts

Public ContactJin Hu

Fudan University Huashan Hospital

286644104@qq.com+86 021 52889999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026